Beth Taylor is VP at ENDOCYTE INC (ECYT). They have made 8 open-market trades across 3 companies since 2018, most recently 2025-03-14.
4 open-market purchases totalling $313K since 2020, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NOTV | SELL | 2025-02-18 | 2025-02-20 | $4.01 | $18K | -34.6% | -31.8% | -52.5% |
| NOTV | SELL | 2025-01-31 | 2025-02-04 | $4.47 | $9K | -16.0% | -40.9% | -54.7% |
| NOTV | BUY | 2022-02-18 | 2022-02-22 | $23.07 | $115K | -4.3% | -9.1% | -47.6% |
| NOTV | BUY | 2021-05-13 | 2021-05-17 | $23.14 | $50K | +9.9% | +38.3% | +29.9% |
| BASI | BUY | 2021-03-05 | 2021-03-05 | $17.70 | $89K | -19.3% | N/A | N/A |
| BASI | BUY | 2020-05-19 | 2020-05-21 | $4.43 | $59K | +8.2% | +1.4% | -6.2% |
| ECYT | SELL | 2018-10-05 | 2018-10-09 | $15.56 | $219K | +56.5% | +57.7% | N/A |
| ECYT | SELL | 2018-08-28 | 2018-08-29 | $20.00 | $158K | +5.2% | -4.5% | +26.9% |
| ECYT | SELL · 10b5-1 | 2018-08-20 | 2018-08-22 | $18.20 | $5K | +12.9% | -0.8% | +33.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.